Cancer News and Research

Latest Cancer News and Research

e-Therapeutics commences enrollment in ETS2101 phase I trial for brain cancer

e-Therapeutics plc announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites.

19 Jun 2012

Zebrafish provides insight into human melanoma

A transparent member of the minnow family is providing researchers at Weill Cornell Medical College in New York City with insight into human melanoma - a form of skin cancer - that may lead to new or repurposed drug treatments, for skin and other cancers.

19 Jun 2012

Commensal bacteria essential to fight off viral infections

Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways - from helping digest food to the development of a healthy immune system.

19 Jun 2012

FORMA, TD2 leverage synergistic capabilities to jointly develop transformative cancer therapies

FORMA Therapeutics and TGen Drug Development (TD2) today announced an agreement to jointly develop transformative cancer therapies, leveraging the synergistic capabilities of both organizations.

19 Jun 2012

Single-dose vaccine for treatment of cocaine addiction

A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating cocaine addiction is described in an article published Instant Online in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc.

19 Jun 2012

Delcath includes second-generation hemofiltration cartridge in chemosaturation system EAP

Delcath Systems, Inc. today announced that the Company has amended its Investigational New Drug (IND) application and its Expanded Access Program (EAP) to include the use of the second-generation hemofiltration cartridge of the Company's proprietary chemosaturation system.

19 Jun 2012

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced new clinical data presented in an oral presentation for ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use at the 17th Congress of the European Hematology Association (EHA).

19 Jun 2012

Study on identification of novel stem cell population in neuroblastoma to be presented at ANR conference

Dr. Eugene Kim, a pediatric surgeon with Texas Children's Cancer Center and assistant professor of surgery at Baylor College of Medicine (BCM), and Dr. Jason Shohet, chair of the Neuroblastoma Research Program at Texas Children's Cancer Center and associate professor in the Section of Hematology-Oncology at BCM, will speak at the Advances in Neuroblastoma Research (ANR) conference about the identification of a novel stem cell population in neuroblastoma.

19 Jun 2012

Pediatric treatment regime for ALL patients improves chances of long-term survival

Acute lymphoblastic leukemia (ALL), usually found in pediatric patients, is far more rare and deadly in adolescent and adult patients. According to the National Marrow Donor Program, child ALL patients have a higher than 80 percent remission rate, while the recovery rate for adults stands at only 40 percent.

18 Jun 2012

Multi-institutional research uncovers new mechanism for treatment of lung cancer

A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide.

18 Jun 2012

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

Two studies published back-to-back in last week's Nature applied DNA blood testing using the BEAMing technology to detect drug resistance mediated by KRAS mutations in colorectal cancer patients months before treatment failure was observed.

18 Jun 2012

Edluar for insomnia treatment receives regulatory approval in Europe

Orexo AB is pleased to report that Edluar has received regulatory approval in Europe, according to information supplied by Meda AB, Orexo's global commercial partner for the product.

18 Jun 2012

CINJ commences enrollment in three-drug combination trial for breast cancer

Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.

18 Jun 2012

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.

18 Jun 2012

Multi-year initiative to help people live longer and better

With 10,000 Americans turning 65 every day - and according to new research released today, a majority of them expect to live to nearly 90 - the celebration of older Americans is a developing trend, and more people are aspiring to live longer and better than ever before.

18 Jun 2012

Concord Medical acquires 52% equity ownership in Chang'an Hospital

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has closed the acquisition of 52% equity ownership in Chang'an Hospital, a leading non-public general hospital located in Xi'an, Shaanxi Province.

18 Jun 2012

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.

18 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

Spectros introduces OnCall wireless remote access to view real-time patient results

Spectros Corporation announces the successful launch of OnCall wireless remote access for viewing real-time patient results on T-Stat white light tissue oximeters.

18 Jun 2012

Is curry good for you?

There have been several news stories over the years reporting that curry may be good for us. Most of them refer to a chemical in curry, known as curcumin.

18 Jun 2012

Cancer News and Research

Latest Cancer News and Research

e-Therapeutics commences enrollment in ETS2101 phase I trial for brain cancer

Zebrafish provides insight into human melanoma

Commensal bacteria essential to fight off viral infections

FORMA, TD2 leverage synergistic capabilities to jointly develop transformative cancer therapies

Single-dose vaccine for treatment of cocaine addiction

Delcath includes second-generation hemofiltration cartridge in chemosaturation system EAP

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Study on identification of novel stem cell population in neuroblastoma to be presented at ANR conference

Pediatric treatment regime for ALL patients improves chances of long-term survival

Multi-institutional research uncovers new mechanism for treatment of lung cancer

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

Edluar for insomnia treatment receives regulatory approval in Europe

CINJ commences enrollment in three-drug combination trial for breast cancer

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Multi-year initiative to help people live longer and better

Concord Medical acquires 52% equity ownership in Chang'an Hospital

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Agility MLC's new design provides better dose sculpting capabilities

Spectros introduces OnCall wireless remote access to view real-time patient results

Is curry good for you?

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Newsletters you may be interested in